Reduced MNDA transcripts are observed in both familial and sporadic MDS cases (156, 157), impacting programmed cell death in myeloid progenitor cells and enhancing tumor necrosis factor-related apoptosis inducing ligand (TRAIL)-induced cell death sensitivity in granulocyte-macrophage progenitors (158). The gene discussed is MNDA; the disease is myelodysplastic syndrome.